Janice M. Walshe
St. Vincent's University Hospital(IE)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Cancer Risks and Factors
Most-Cited Works
- → Palbociclib and Letrozole in Advanced Breast Cancer(2016)2,879 cited
- → Amenorrhea in Premenopausal Women After Adjuvant Chemotherapy for Breast Cancer(2006)352 cited
- → Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer(2023)205 cited
- → Overall survival (OS) with first-line palbociclib plus letrozole (PAL+LET) versus placebo plus letrozole (PBO+LET) in women with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer (ER+/HER2− ABC): Analyses from PALOMA-2.(2022)171 cited
- → Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes(2007)166 cited
- → Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial(2018)158 cited
- → Cardiac Toxicity and Efficacy of Trastuzumab Combined with Pertuzumab in Patients with Trastuzumab-Insensitive Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer(2008)157 cited
- → Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer(2024)157 cited
- → Clinical Aspects of Inflammatory Breast Cancer(2006)136 cited
- → PALOMA-2: Primary results from a phase III trial of palbociclib (P) with letrozole (L) compared with letrozole alone in postmenopausal women with ER+/HER2– advanced breast cancer (ABC).(2016)110 cited